Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Enters Bridge Credit Agreement for up to €9.25 Billion

NEW YORK – Thermo Fisher Scientific said on Thursday that on April 17, it entered into a bridge credit agreement with JPMorgan Chase and Morgan Stanley Senior Funding for up to €9.25 billion ($9.96 billion).

The company had announced on March 3 that the lenders had committed to the debt financing in connection with its proposed acquisition of Qiagen.

Under the terms of the agreement, Thermo Fisher is obtaining a 364-day senior unsecured bridge loan facility in the principal amount of up to €9.25 billion. Loans under the agreement will be available to fund the purchase of equity securities of Qiagen and to pay all or a portion of the cost incurred in connection with this.

Thermo Fisher can draw on the funds on the closing date of the acquisition and again within 120 days after the closing date.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.